Introduction
Over the recent years, invasive pulmonary aspergillosis (IPA) has become a frequent cause of fungal pneumonia in both neutropenic and non-neutropenic immunosuppressed from the respiratory tract and galactomannan or beta-Dglucan assays have variable sensitivities and specifi cities depending on the patient ' s underlying condition, and the presence of neutropenia [1, 5] .
In this context, the development of an in vivo method for early diagnosis of the disease would enable earlier treatment decisions, especially when the inoculum remains limited, and therefore may transform the prognosis of the disease.
Fibered Confocal Fluorescence Microscopy (FCFM), also called probe-based confocal endomicroscopy (pCLE), is a new optical imaging technique based on the principle of confocal fl uorescence microscopy, where the microscope objective is replaced by a fi ber-optic probe. In human lung exploration, the probe can be introduced into the working channel of a bronchoscope, down to the distal lung areas, and produces optical microimaging of the acinus [6 -8] . In a previous study, we used FCFM in vivo in a rodent experimental IPA model [9] . In the non-neutropenic, immunosuppressed animals, we observed, in areas of lung micro-abscesses, infi ltration of fl uorescent host cells. These did not appear specifi c for IPA, as it was also observed in G. argillacea infections and in non-specifi c sterile infl ammation. During this study, we found that the spatial resolution of FCFM makes it possible to image in vivo an auto-fl uorescent Aspergillus strain expressing TAG-RFP. However, wild strains of A. fumigatus , which are not autofl uorescent at 488 nm wavelength excitation, were not directly detectable in vivo . Therefore, in order to image IPA in other animal models and in humans, FCFM should be used coupled to a fl uorescent tracer that would specifi cally target Aspergillus .
Recently, Lionakis et al . described a cyclic peptide, c(CGGRLGPFC)-NH2, that is able to specifi cally bind to the hyphae of the invasive form of A. fumigatus [10] . This group also showed that the peptide could be radiolabeled and used for the detection of invasive aspergillosis in rats, 2 h after receiving an i.v injection for single-photon emission computerized tomography (SPECT) [11] .
In this study, we investigated the hypothesis that the use of this cyclic peptide, labeled with FITC-fl uorophore, could be used as a specifi c fl uorescent tracer for IPA detection in vivo using FCFM.
Materials and methods

Study design
We fi rst investigated the in vitro labeling specifi city of the cyclic peptide [FITC] to the Aspergillus biofi lm, by comparing it with a biofi lm from G. argillacea . Then, we investigated the in vivo A. fumigatus detection in experimental pulmonary aspergillosis in rats. For this purpose, rats were immunosuppressed by dexamethasone and a low protein diet, and were infected with A. fumigatus or G. argillacea , or inoculated with sterile PBS. Four days after inoculation, rats were studied by FCFM, 2 h after the i.v injection of the fl uorescent peptide.
Growth of fungal strains and harvesting of conidial inocula
Aspergillus fumigatus and Geosmithia argillacea strains were obtained from clinical isolates at the University Hospital of Rouen, France. Both strains were grown on Sabouraud dextrose agar (Biomerieux, France) at 37 ° C, 3 and 7 days, respectively. Conidia were harvested and suspended in 2 ml of PBS, supplemented with 0.05 ml Tween 80 and vortexed. The number of conidia per milliliter was counted and adjusted to the required concentration of 1 ϫ 10 5 conidia per ml using a numeration Kova-cell.
Aspergillus and Geosmithia biofi lms
Biofi lms were obtained after deposition of the fungal suspension into 96-well plates (NUNC, France) and incubated at 37 ° C for 24 h, as described [9] . After three washings with PBS [12] the early phase of the fi lamentous biofi lm was observed by optical microscopy, showing a network of hyphae adherent to each other and to the surface of the wells. Non-inoculated wells were also included as negative controls. Tests were performed in triplicate.
Animals
The protocol was approved by the Rouen University Ethical animal care and use committee (N/01-09-10/13/09-13). A total of 29 Sprague Dawley (CD) albino male rats (Charles River Laboratories, France) each weighing 150 g were used in the study. Rats were housed in pre-sterilized fi lter-topped cages, examined daily and weighed every two days.
Experimental lung A. fumigatus and G. argillacea infections
The experimental fungal pneumonia model was adapted from the pulmonary aspergillosis model described by Ullmann, with slight modifi cations, as described in previous studies [13] . After 15 days under immunosuppressing conditions using 12 mg/kg of Dexamethasone three times a week and a low protein diet, rats were inoculated, under general anaesthesia, with 50 μ l of the fungal suspension (1 ϫ 10 5 conidia/ml), slowly administered through the nasal route. Thirteen rats were infected with A. fumigatus , six with G. argillacea and 10 were instilled with sterile PBS solution. Rats were imaged in vivo with FCFM 4 days after inoculation. applied onto these areas. After lung FCFM imaging, several lung fl uorescent areas and the nearest non-fl uorescent areas were sampled for histological examination. Animals were euthanized at the end of the procedure and the lungs were processed for bacteriological and fungal culture, as well as for histopathological examinations as described elsewhere (9).
Quantitative analysis of the in vivo fl uorescence signal
Fluorescence intensity (FI) was quantifi ed using the MedViewer software. A representative FCFM image was selected from each recorded sequence, in order to measure the median FI of the pixels. FI from the lung areas were normalized to the fl uorescent signal detected on the inner part of the thoracic wall. Results were expressed in (lung areas explored/thoracic wall) FI ratio for each animal. This procedure allowed inter-animal comparisons of FI.
Tissue analysis
After Cellvizio imaging, the rats were euthanized and the accessory lobe was aseptically removed for bacteriological and fungal cultures. For histopathological examination, an intratracheal injection of cryogenic-gel (Cryomatrix, Thermoscientifi c, USA) at a constant pressure allowed the re-expanding of the other pulmonary lobes. These lobes were frozen and cut into 5 μ m sections that were processed for fl uorescence microscopy (unstained slide) or stained with Hematoxylin-Eosin (H & E) for optical microscopy examination.
Statistical analysis
Analysis of the tissue samples allowed the classifi cation as ' mould invaded ' or ' not mould invaded ' , based on the identifi cation of in situ fungal invasion from the histology slides Fluorescence intensity ratios were compared to their histological counterpart using the MannWhitney test. A p value Ͻ 0.05 was considered significant. A ROC curve was computed to assess the specifi city and sensitivity of FCFM with the peptide [FITC] for the diagnosis of IPA.
Results
In vitro, the cyclic peptide [FITC] specifi cally binds to the early phase of A. fumigatus biofi lm Figure 1 shows the analysis of conventional (A & F) and fl uorescence (B to E and G to I) microscopy of A. fumigatus and G. argillacea cultures, before and after incubation with the fl uorescent peptide. Fluorescence microscopy at 494 nm showed no detectable autofl uorescence
The fl uorescent peptide
The cyclic peptide c(CGGRLGPFC)-NH2, was synthesized (Polypeptide Laboratories, Strasbourg, France) and labeled with FITC on the free amine of an acetyl lysine residue, added to the c-terminal cystein (QUIDD , Rouen, France). Complete formula of the labeled peptide was [FITC] AcK-c-(CGGRLGPFC)-NH2. Its fl uorescence optimal excitation is at 494 nm with an emission peak at 525 nm.
In vitro binding peptide [FITC] assay
To assess the binding specifi city of the peptide to Aspergillus hyphae, 1 nmol of peptide [FITC] was added to wells containing A. fumigatus biofi lm or G. argillacea biofi lm and to control wells. After 30-min incubation and three PBS washings, qualitative analyses of the fl uorescent signal were performed by fl uorescence microscopy and the photomicrographs were analyzed with the Histolab software (Microvision Instrument). Quantitative analyses were performed by spectrofl uorometry (Hitachi F7000 Fluorescence Spectrophotometer) with excitation at 494 nm and detection at 525 nm. Each well was also imaged with FCFM using a Cellvizio Lab device (Maunakea Technologies, Paris, France). Fluorescence Intensity values were expressed as means from triplicates and are representative of at least three separate experiments.
Fibred confocal fl uorescence microscopy
The FCFM imaging system Cellvizio Lab uses a miniprobe that conducts a fl uorescent excitation light at 488 nm and detects a fl uorescent emission between 500 and 620 nm. It provides images with a 5 μ m lateral resolution within a 600 μ m fi eld of view. FCFM data were recorded in real time. The fl uorescent signal was analyzed using the dedicated software MedViewer 1.1.0 Signal Quantifi cation Toolbox (Mauna Kea Technologies).
For in vitro analyses, the Cellvizio probe was placed directly on top of the biofi lms or free-bottomed wells. Distribution and intensity of the fl uorescence signal were analyzed. For in vivo analyses, Cellvizio images were recorded four days after the rat inoculations. In each group, the animals received an i.v injection of 0.3 ml of peptide [FITC] solution (30 nmol) or saline solution and FCFM images were acquired 2 h afterwards [10] . Rats were anesthetized by intraperitoneal injection of Xylazine and Ketamine (12 mg/kg and 80 mg/kg, respectively), and placed in supine position. The lungs were exposed by thoracotomy. The technique allowed the macroscopic observation and localization of healthy and pathological areas on the lung surface. FCFM imaging was performed with the probe from A. fumigatus and G. argillacea biofi lms (Fig. 1B,  1G ). After 30-min incubation with the peptide [FITC] and three rinses, a strong fl uorescence appeared specifi cally on the A. fumigatus biofi lm, with none detectable with those of G. argillacea (Fig. 1C, 1H ).
This was confi rmed by spectroscopy analysis that showed the absence of detectable autofl uorescence from the A. fumigatus and G. argillacea cultures, as well as from RPMI control wells before incubation with the peptide (Fig. 2) . After incubation with the peptide and three rinses, a strong fl uorescence appeared on A. fumigatus cultures but not in the fungal-free RPMI and G. argillacea wells (Fig. 2 , p Ͻ 0.05). After successive rinses, a decreasing intensity of the fl uorescent signal was observed from A. fumigatus , due to partial detachment of hyphaes from the plates, but could still be detected after the 12th rinsing (Fig. 2) .
FCFM imaging of the biofi lms showed a specifi c binding of the peptide [FITC] to A. fumigatus (Fig. 1D, 1E ), but no FCFM signal was observed from G. argillacea biofi lm (Fig. 1I, 1J ).
In vivo, FCFM signal of lung aspergillosis after the peptide [FITC] i.v. injection is signifi cantly higher compared to lung aspergillosis FCFM imaging without peptide [FITC] , and to other fungal FCFM imaging Twenty-nine animals were used for the in vivo imaging study, including 13 Aspergillus infected rats, 10 PBS instilled rats and six Geosmithia -infected rats. Among them, 15 animals (seven Aspergillus , fi ve PBS, four Geosmithia -instilled rats) received the peptide [FITC] i.v.
A total of 145 lung areas were imaged with FCFM and sampled for histopathology analysis, including 68 areas taken from peptide-injected animals.
Thirty-one subpleural areas were imaged in vivo from the PBS group. No signifi cant FCFM signal was seen, except from three infl ammatory areas where a moderate infi ltration of fl uorescent infl ammatory cells was recorded (Fig. 3) . Histological analyses of the samples from the PBS rats showed normal lung structures or non-specifi c infl ammation and cultures inoculated with samples of these animals were negative. From the PBS group, the median fl uorescence intensity (FI) ratio of these same animals (interquartile range; lung areas/inner thoracic wall) was 0. Seventy-nine macroscopically abnormal lung areas were found in the Aspergillus -instilled animals, including 41 from the group that did not receive the peptide. From the whole Aspergillus -instilled group, 36 areas were confi rmed as IPA foci after H & E staining and optical microscopy analysis, and 43 showed non-specifi c infl ammation (Fig. 5) . Systematic analysis of frozen sections from the whole lungs showed six other IPA foci, which were centrally localized within the lung and therefore not detectable on gross examination or FCFM imaging of the lung surface.
From the Aspergillus -instilled animals that did not receive the peptide, a signifi cant cellular fl uorescent signal was detected in vivo on the macroscopically abnormal Fig. 3 In vivo FCFM imaging in PBS controls, Aspergillus infected rats, and Geosmithia argillacea infected rats, before or after the peptide injection. (A) FCFM signal from a macroscopically normal pulmonary area after peptide injection. (B) FCFM signal from a focal infl ammatory area in PBS instilled rat after peptide injection. (C, D) FCFM signal from pulmonary micro-abscesses in A. fumigatus infected rat, before (C) and after (D) the peptide [FITC] i.v injection. (E, F) FCFM signal from pulmonary micro-abscesses in G. argillacea infected rat, before (E) and after (F) the peptide [FITC] i.v injection. This Figure is areas with FCFM (Fig. 3) . From these areas, the signal was not different in histology-proven IPA foci ( n ϭ 17) compared to infl ammatory areas without IPA ( n ϭ 24; FI ratio ϭ 1.05 [0.92 -1.47] and 1.04 [0.92 -1.21], respectively, p ϭ 0.39, Mann-Whitney, Fig. 4) .
Thirty-eight macroscopically abnormal areas were detected in vivo from the Aspergillus -infected rat group that received the peptide, from which 19 corresponded to IPA foci on biopsy (Fig. 5) . FCFM signal differed between histology-proven IPA foci and infl ammatory areas by the presence of a diffuse stromal fl uorescence associated with fl uorescent cells (Fig. 3D) . The median FI ratio from IPA areas imaged after peptide injection was 1.83 [1.52 -2.6], signifi cantly higher compared to the infl ammatory areas (FI ratio 1 [0.94 -1.1]), PBS-instilled rats and G. argillacea micro-abscesses from peptide-injected animals, as well as to IPA foci from Aspergillus -infected rats without peptide injection ( p Յ 0.002 for all comparisons, Mann-Whitney test; Fig. 4) .
Discussion
FCFM or probe-based confocal laser endomicroscopy (pCLE) is a new endoscopic technique that allows in vivo microscopic imaging of different tissues and organs under healthy and pathological conditions, in real time [14] . Until recently, the technique has mainly used endogenous autofl uorescence or simple fl uorescent contrast agents to visualize the in vivo cellular and interstitial organization of tissues in both animal models and humans [6, 15] . The use of molecular contrast compounds in conjunction with pCLE now makes it possible to extend the microimaging capabilities to specifi c molecular and cellular targets in vivo , in situ .
This microimaging strategy presents several advantages compared to nuclear imaging using similar targeted probes and SPECT [11] , including the lack of medical irradiation, the possibility for a bedside exploration, and a better spatial localisation of the lesion that allows in situ sampling Fig. 4 FCFM fl uorescence intensity, as expressed by lung/inner thoracic wall ratios, 2 hours after i.v. injection of the peptide [FITC] or after saline i.v. injection. From left to right: sterile lungs from PBS-instilled rats, Geosmithia micro-abscesses, non-specifi c infl ammation from Aspergillus -instilled rats (No IPA), and invasive pulmonary aspergillosis micro-abscesses (IPA). Without peptide injection, FCFM fl uorescence intensity did not allow the discrimination of Aspergillus invaded areas against sterile areas ( p ϭ 0.39, Mann-Whitney test). After peptide administration, FCFM signal increased signifi cantly on IPA areas, compared to IPA foci in rat that did not receive the peptide, and to all other groups ( p Ͻ 0.001, Mann-Whitney test).
Downloaded from https://academic.oup.com/mmy/article-abstract/51/4/352/1026595 by guest on 27 March 2019 during the procedure. Pilot studies using this strategy have recently been published, which provided specifi c confocal imaging of molecular probes in precancerous conditions of the oral cavity ex vivo [16] and of colonic dysplasia and cancer in vivo [17 -19] .
In this study, we show that targeted visualization of an Aspergillus -binding peptide makes it possible to detect invasive pulmonary aspergillosis in vivo with a specifi city and sensitivity close to 95%. Here, we used the cyclic peptide c(CGGRLGPFC)-NH2 described by Kontoyiannis and co-workers [11] that was selected for its in vitro binding properties on Aspergillus , which we labeled using FITC. We show that the fl uorescent peptide can be visualized by FCFM technology both in vitro and in vivo , and specifically targets Aspergillus after i.v. administration, compared to aspecifi c lung infl ammation areas and other invasive fungal lung infection such as caused by G. argillacea .
The model used in our study reproduces the immune state caused by steroid therapy in pulmonary chronic diseases, which is a risk factor for broncho-invasive aspergillosis [13] . The synthetic glucocorticoid dexamethasone was chosen because it has the highest anti-infl ammatory and immunosuppressive potency and is also commonly used in the acute phase of severe exacerbations of chronic bronchitis. Using this model, rats that had no neutropenia and disseminated disease [9] , and the pulmonary lesions were mainly composed by neutrophilic and monocytic infi ltration associated with infl ammatory necrosis, intra-alveolar hemorrhage and angio-invasion [20] . This reproduces the human form of necrotizing pulmonary aspergillosis. This condition is known to be diffi cult to diagnose in humans due to the underlying respiratory conditions that limit the invasive lung explorations, and the low specifi city of the clinical and radiological presentation. Our data suggest that in this situation, FCFM associated with specifi c targeting of the invasive form of A. fumigatus may represent a valuable tool for the diagnosis and follow-up of the disease.
Based on our in vitro study, we expected to observe a fi brillar fl uorescent signal from the mycelium invasion area. Instead, we detected a more diffuse fl uorescence, resulting in a signifi cant increase of fl uorescence intensity from the A. fumigatus lung micro-abscesses. Because of its absence in G. argillacea micro-abscesses, this diffuse fl uorescent signal does not appear to be related to neutrophils and monocytes local activation or to a non-specifi c host-pathogen interaction. This suggests that a specifi c peptide-related signal would also be observed from IPA lesions developing in neutropenic hosts. However, because of the absence of neutrophilic infi ltration, it cannot be excluded that a more homogeneous binding to the hyphal network might result in a different, i.e., less diffuse or fi brillar, signal.
On the other hand, previous experimental data suggest that this diffuse signal may be due to the Aspergillus biofi lm formation in IPA and to the peptide structural properties in relation to its selection process [10, 11] . A. fumigatus undergoes morphological modifi cations during its invasion of the lung. Histological examination of invasive pulmonary aspergillosis samples indicates the presence of a local biofi lm, consisting in an intertwined hyphae complex with matrix production [21, 22] . From Kontoyiannis group ' s previous work [10] , it appears that the cyclic peptide shares structural similarities with the Aspergillus biofi lm matrix, which explains its binding to the invasive aspergillosis. However, this does not appear to alter the diagnostic value of the method in our series. On the contrary, this biofi lm matrix binding property may add some specifi city to the imaging procedure in selecting areas of fungal invasion associated with biofi lm formation, as opposed to simple areas of contamination. Our study represent a ' proof of concept ' that using a peptidomimetic approach, FCFM has potential in diagnosing invasive aspergillosis in immunocompromised conditions. As such, several further experimental steps will be needed before it could be translated into clinical practice. In particular, several limitations of this study should be underlined:
This study only assessed (a)
A. fumigatus and G. argillacea experimental infections, both of which are known to be responsible for invasive pulmonary infection in non-neutropenic patients [23, 24] . However, we cannot strictly exclude that other fungal, bacterial or infl ammatory lung process that may be associated with IPA may impact the accuracy of the method, especially in neutropenic hosts. Along this line, previous in vitro studies using the cyclic peptide against several fungal clinical isolates have demonstrated the absence of binding to A. fl avus , but a signifi cant binding to non-A . fumigatus Aspergillus species, and to a lesser degree to Rhizopus species [10] . Therefore, future studies are needed to assess the potential of the method to differentiate Aspergillus species from those of the Zygomycetes . In humans, the use of the cyclic peptide for (b) in vivo molecular imaging of invasive aspergillosis would have some technical advantages and diffi culties compared to the rat model. Firstly, as opposed to rats where a transthoracic approach had to be used, human distal lung exploration with FCFM (or alveolar pCLE) is well tolerated and easy to realize during a fi beroptic bronchoscopy procedure [6] . Alveolar pCLE can be performed under local anesthesia in spontaneously breathing patients, with no severe adverse event reported to date.
Secondly, targeting an area of consolidation within the lung, i.e., an area of invasive aspergillosis during bronchoscopy is possible and very effi cient using navigational bronchoscopy [25] . Thirdly, in addition to the detection of a specifi c aspergillosis biofi lm signal, the technique can be easily used to target the sampling of the suspected area, even in the distal lung, using a guide sheath that allows the introduction of the pCLE probe followed by the biopsy forceps [26] . Therefore, the peptide [FITC] i.v. administration along with the use of navigational bronchoscopy and probe-based confocal endomicroscopy has the potential to specifi cally diagnose and help to sample human invasive aspergillosis.
On the other hand, as opposed to the rat lung, the human distal lung is known to have a strong autofl uorescence at 488 nm excitation due to the elastin interstitial framework of the acinus. Whereas the spatial distribution of the elastin network in the distal lung has recently been described using pCLE [6] , this may make it diffi cult to distinguish the fl uorescent peptide signal from the elastin signal, for FI ratio determination, if conjugated with a 488 nm excitable fl uorophore. In this regard, tracers may be labeled with infrared fl uorophores, instead of fl uorescein, and then be used with a 660 nm Cellvizio, as the lung is known to have no detectable autofl uorescence with pCLE at this excitation wavelength [26] . Another strategy would be to develop peptide aptamers interfering with intracellular Aspergillus hyphae proteins, which would allow morphometric distinction between the fi bered elastin framework and Aspergillus .
In conclusion, our study shows that in vivo optical microimaging of invasive aspergillosis is possible in immunosuppressed rats, using a peptidomimetic approach and confocal microendoscopy. Future experimental and clinical studies will determine the impact of these fi ndings on the clinical management of this diffi cult-to-diagnose and highly fatal disease.
